Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-15

Clinical Trial Update: Effect of Dotinurad in Hyperuricemia With Hypertension [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dotinurad for hyperuricemia (with gout) and hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dotinurad (dotinurad)

Snippet

Sponsor: Saga University | Conditions: Hyperuricemia or Gout, Hypertension | Phase 4 | Status: RECRUITING